Sensorion S.A. EBIT

The latest EBIT for ALSEN.PA is $1.5B as of December 2023. That compares with $2.1B in the prior-year period — down 28.3% year over year. That is below the Healthcare sector average of $130B. Investors often review this figure alongside Sensorion S.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ALSEN.PA's EBIT moved from $2.1B to $1.5B — a 28.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sensorion S.A.'s operating scale or balance-sheet position.

Against Healthcare companies, ALSEN.PA currently prints $1.5B for EBIT, while the sector average sits near $130B. That is roughly 98.9% below the sector mean. Large gaps often invite a closer look at Sensorion S.A.'s growth, margins, and balance sheet.

A EBIT figure of $1.5B for ALSEN.PA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $130B. Explore the charts below for those layers of context.

After noting ALSEN.PA's EBIT ($1.5B), review year-over-year change from $2.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.